TrialStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2017

[Radiochemotherapy improves failure-free survival in stage III endometrial cancer : Final results of the PORTEC-3 trial].

David Krug et al.PubMed ↗Publisher ↗

No numbers read from the abstract.